ISG15 and COVID-19: Dexamethasone strongly inhibited plasma ISG15 concentration in patients with COVID-19, and thus demonstrated the capability of modulating cytokines and transcription factors that play a role in the antiviral host response but are also linked to cytokine hyperresponsiveness.